Envisagenics

Long Island City, NY · Founded 2014 · Privately Held (backing)

Developer of a bioinformatics platform designed to accelerate the development of novel therapeutics. Envisagenics is based in Long Island City, NY and was founded in 2014. Its last known valuation is $150 million. It has raised $40.5 million across 2 recorded rounds; the latest was a $19.2 million early-stage round in Sep 2021.

Last price · $/share
—
Implied valuation
$150.0M
Total raised
$40.5M
Last round
Early Stage VC
Sep 2021

Who backs Envisagenics?

24 investors
InvestorType
SV AngelVenture capital
National Institutes of HealthOther
M12Other
Madrona Venture GroupVenture capital
HawktailVenture capital
New York VenturesVenture capital
Dolby Family VenturesVenture capital
Bristol-Myers Squibb—
Third Kind Venture CapitalVenture capital
Upsher Management CompanyFamily office
+ 14 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Envisagenics investors

24 investors are on record for Envisagenics, including SV Angel, National Institutes of Health, M12 and Madrona Venture Group. By type, the record holds 6 venture capital firms and 1 family office. The early-stage round in Sep 2021 drew 24 investors.

Free account
More of Envisagenics with a free account
  • ·The complete investor list: 24 names
  • ·Watch Envisagenics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 24 firms already write checks for companies like Envisagenics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View